In this issue of Blood, Miraki-Moud et al demonstrate that the majority of acute myeloid leukemias (AMLs) have low expression of argininosuccinate synthetase-1 (ASS1), rendering AML cell lines and primary AML blasts dependent on exogenous arginine and sensitized to arginine deprivation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1182/blood-2015-05-643411 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!